Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AdvaMed, CMS Take Conflicting Views On FDA Lab Test Waiver Requirements

This article was originally published in The Gray Sheet

Executive Summary

FDA will need to consider diverging opinions from outside groups as it develops a policy on the requirements for diagnostic test manufactures seeking permission to market assays to laboratories that are under minimal government oversight

You may also be interested in...



FDA Says Final CLIA Waiver Guidance Eases Burdens; Industry Isn’t Satisfied

Final guidelines to companies developing point-of-care diagnostic tests for use in less sophisticated laboratories offer more leeway in clinical trial design than FDA initially proposed

FDA Says Final CLIA Waiver Guidance Eases Burdens; Industry Isn’t Satisfied

Final guidelines to companies developing point-of-care diagnostic tests for use in less sophisticated laboratories offer more leeway in clinical trial design than FDA initially proposed

FDA User Fee Commitments Drive Diagnostics Office Priorities In 2008

In vitro diagnostic issues promise to be an active area for FDA and device industry lobbyists this year in response to a laundry list of commitments agreed to by the agency as part of user fee reauthorization legislation

Related Content

UsernamePublicRestriction

Register

MT023014

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel